BazEkon - Biblioteka Główna Uniwersytetu Ekonomicznego w Krakowie

BazEkon home page

Meny główne

Autor
Świeczkowski Damian (Studenckie Koło Prawa Farmaceutycznego, Gdański Uniwersytet Medyczny), Pietrzak Bartosz (Studenckie Koło Prawa Farmaceutycznego, Gdański Uniwersytet Medyczny), Zimmermann Agnieszka (Gdański Uniwersytet Medyczny)
Tytuł
Generic Substitution in The View of Pharmaceutical Scientists from Polish Medical Universities
Źródło
Journal of Health Policy and Outcomes Research, 2014, nr 2, s. 50-57, rys., tab., bibliogr. 12 poz.
Słowa kluczowe
Rynek farmaceutyczny, Prawo farmaceutyczne, Leki, Apteki
Pharmaceutical market, Pharmaceutical law, Drugs, Pharmacy
Uwagi
summ.
Abstrakt
Generic substitution is a commonly observed phenomenon in pharmacy. It is promoted as part of the state drug policy and leads to a reduction in expenditure on drugs, facilitates the purchase of medicines by patients and improves compliance. So far researchers have focused on the evaluation of substitution by pharmacists, doctors or patients. The present study investigates the opinion of Pharmaceutical Faculties employees. The respondents acknowledge the importance of generic substitution; nevertheless they do not have a clear opinion on the effectiveness and safety of generic products. The respondents' experience may have had a significant impact their opinion, especially of those working in the community pharmacies. The studies is part of a broader framework of the national debate on generic substitution. Undoubtedly the approach to generic substitution is one of the contemporary challenges of the pharmaceutical law(original abstract)
Pełny tekst
Pokaż
Bibliografia
Pokaż
  1. Posner J., Griffin J., Br J Clin., Generic Substitution, Pharmacol. 2011; 72(5): 321-322
  2. Act on the Reimbursement of Medicines, Foodstuffs Intended for Particular Nutritional Uses and Medical Devices, Poland, 2012
  3. The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. ​Available from: http://en.urpl.gov.pl; [Accessed: 14.12.2014]
  4. Hakonsen H. et all, Generic substitution: an additional challenge for adherence in hypertensive patients?. Curr Med Res Opin. 2009, 25(10): 2515 - 2521
  5. Durdeon M., Hughes D., Generic and therapeutic substitutions in the UK: are they a good thing?. Br J Clin Pharmacol 2010, 70(3): 335-341
  6. Wpływ ustawy o refundacji leków na dostęp pacjentów do farmakoterapii (..) Ocena skutków regulacji. Raport Infarma, Warszawa 2014
  7. Handoo S., Arora W., Khera D., A comprehensive study on regulatory requirements for development and filing of generic drugs globally. Int J Pharm Investig, 2012; 2(3): 99 - 104
  8. Stupans I., McKinnon R., Generic substitution in the treatment of epilepsy: patient attitudes and perceptions. Epilepsy Behav. 2013; 26(1): 64-66
  9. Hakonsen H., Eilertsen M. et all, Generic substitution: an additional challenge for adherence in hypertensive patients?. Curr Med Res Opin. 2009; 25(10): 2515 - 2521
  10. Gill L., Helkkula A., Cobelli N., White L., How do customers and pharmacists experience generic substitution?, International Journal of Pharmaceutical and Healthcare Marketing 2010; 4(4): 375 - 395
  11. LeLourier J. et all, Clinical consequences of generic substitution of lamotrigine for patients with epilepsy, Contemporary Issues in Neurological Practice 2008; 2179 - 2186
  12. Koskinen H., Ahola E. et all, The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland. Health Economics Review 2014; 4(9)
Cytowane przez
Pokaż
ISSN
2299-1247
Język
eng
URI / DOI
http://dx.doi.org/10.7365/JHPOR.2014.2.6
Udostępnij na Facebooku Udostępnij na Twitterze Udostępnij na Google+ Udostępnij na Pinterest Udostępnij na LinkedIn Wyślij znajomemu